Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/handle/10553/145654
Título: Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study
Autores/as: González Lleó, Ana María 
Brito Casillas, Yeray 
Martin-Santana, Virginia
Gil Quintana, Yaiza María 
Tugores Céster, Antonio 
Scicali, Roberto
Riaño Ruiz, Marta 
Hernández Baraza, Luisa 
Jiménez Monzón,Roberto 
Girona, Josefa
Di Giacomo Barbagallo, Francesco
Masana, Luis
Boronat Cortés, Mauro 
Wägner, Anna Maria Claudia 
Sanchez Hernández, Rosa María 
Clasificación UNESCO: 32 Ciencias médicas
320502 Endocrinología
320501 Cardiología
3205 Medicina interna
Palabras clave: Insulin Sensitivity
Canary-Islands
Gran-Canaria
Cardiovascular Risk
Statin Therapy, et al.
Fecha de publicación: 2025
Publicación seriada: Cardiovascular Diabetology 
Resumen: Background Heterozygous familial hypercholesterolemia (HeFH) is typically associated with a lower prevalence of type 2 diabetes mellitus (T2DM). However, individuals carrying the p.[Tyr400_Phe402del]LDLR mutation, which is prevalent in Gran Canaria, exhibit an unexpectedly high prevalence of T2DM. This study aimed to investigate whether the p.[Tyr400_Phe402del] LDLR mutation co-segregates with T2DM and other glucose metabolism abnormalities.MethodsA total of 226 individuals were recruited, with 196 included in the final analysis. This included 90 HeFH patients from Gran Canaria (HeFH-GC) carrying the p.[Tyr400_Phe402del]LDLR mutation, 76 first-degree relatives (non-HeFH), and 30 HeFH patients from Italy (HeFH-It) with other LDLR mutations. Clinical, anthropometric, biochemical, and hematological parameters, including insulin resistance and sensitivity, were assessed via oral glucose tolerance tests (OGTT), and indices such as HOMA-IR, HOMA-beta, QUICKI, and the triglyceride-glucose ratio were measured.ResultsAmong HeFH-GC participants, 20% had T2DM, similar to 18.4% in the non-HeFH group (p = NS). HOMA-beta was significantly greater in HeFH-GC patients (86.2 vs. 68.4; p = 0.046). Normoglycemic HeFH-GC individuals had elevated HOMA-IR [2.0 (1.3-2.9) vs. 1.3 (1.0-1.9); p = 0.008]. Compared with HeFH-It patients, HeFH-GC individuals had higher fasting glucose levels (99 vs. 92.5 mg/dL; p = 0.004) and lower 120-min post-OGTT glucose levels (115 vs. 136.5 mg/dL; p = 0.001). Lipid-lowering therapy, hypertension, hypertriglyceridemia, and increased waist circumference were associated with T2DM.ConclusionsHeFH patients from Gran Canaria exhibit a high prevalence of T2DM. The p.[Tyr400_Phe402del]LDLR mutation does not co-segregate with T2DM, but normoglycemic HeFH-GC individuals have greater insulin resistance. Additionally, lipid-lowering therapy, hypertension, hypertriglyceridemia, and increased waist circumference are factors associated with the prevalence of T2DM.
URI: https://accedacris.ulpgc.es/handle/10553/145654
DOI: 10.1186/s12933-025-02857-8
Fuente: Cardiovascular Diabetology [EISSN 1475-2840], v. 24 (1), (Diciembre 2025).
Colección:Artículos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.